Tokyo, Japan

Hideaki Kitajima

This inventor holds 4 USPTO granted patents. Top assignee: Taisho Pharmaceutical Co., Ltd.. Active years: 1999-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideaki Kitajima. Retrieved from https://idiyas.com/inventor/hideaki-kitajima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 75.0

Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Tokyo, JP (1999 - 2000)
  • Toshima-ku, JP (2015)

Company Filing History:


Years Active: 1999-2015

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Hideaki Kitajima

Introduction

Hideaki Kitajima is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions aimed at improving health outcomes. With a total of 4 patents to his name, Kitajima's work reflects a commitment to innovation and public health.

Latest Patents

Among his latest patents is a composition for lowering blood uric acid levels, which is characterized by comprising taurine as an active ingredient. This invention addresses a critical health issue, providing a potential remedy for individuals suffering from elevated uric acid levels. Additionally, he has developed a remedy or preventive for hyperlipemia, showcasing his dedication to tackling various health challenges.

Career Highlights

Kitajima is currently associated with Taisho Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His role at the company allows him to leverage his expertise in developing innovative health solutions. His contributions have not only advanced the company's mission but have also positively impacted the lives of many individuals.

Collaborations

Throughout his career, Kitajima has collaborated with notable colleagues, including Kenji Tsunoda and Akiko Yoneda. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the innovation process.

Conclusion

Hideaki Kitajima's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a dedication to improving health outcomes through scientific advancements. His contributions will continue to influence the field for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…